gadolinium has been researched along with Adverse Drug Event in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 4 (16.00) | 29.6817 |
2010's | 17 (68.00) | 24.3611 |
2020's | 3 (12.00) | 2.80 |
Authors | Studies |
---|---|
Głowacka, K; Jonderko, L; Karłowicz-Bodalska, K; Sauer, N; Szlasa, W; Wiela-Hojeńska, A | 1 |
Asadollahzade, E; Ebadi, Z; Ghadiri, F; Moghadasi, AN | 1 |
Burnette, WB; Crum, K; Markham, LW; Raucci, FJ; Sheybani, A; Soslow, JH | 1 |
Daldrup-Link, HE | 1 |
Longo, D; Napolitano, A; Pasquini, L; Romano, A; Rossi Espagnet, MC; Tomà, P; Visconti, E | 1 |
McNamara, C; Rahmani, G | 1 |
Chavhan, GB; Holowka, S; Shroff, M | 1 |
Abu Alfa, AK; Bauer, K; Belknap, SM; Bhatt, K; Bull, C; Cowper, SE; Edwards, BJ; Fisher, MJ; Hammel, JA; Kanal, E; Laumann, AE; McKoy, JM; Miller, FH; Nardone, B; Raisch, DW; Restaino, J; Saddleton, E; Samaras, AT; Thomsen, HS; West, DP | 1 |
Cohan, RH; Davenport, MS; Ellis, JH | 1 |
Bruder, O; Buss, S; Greulich, S; Jensen, C; Lombardi, M; Mahrholdt, H; Nagel, E; Nothnagel, D; Petersen, S; Pilz, G; Schneider, S; Schwitter, J; Sechtem, U; van Rossum, AC; Wagner, A | 1 |
AlObaidy, M; Ramalho, J; Ramalho, M; Semelka, RC | 1 |
Cascella, M; Catalano, O; Cuomo, A; dell'Aprovitola, N; Filice, S; Fusco, R; Granata, V; Izzo, F; Petrillo, A; Schiavone, V | 1 |
Deray, G; Janus, N; Karie, S; Launay-Vacher, V; Ledneva, E | 1 |
Cianciulli, P; D'Ascola, D; Favilli, B; Filosa, A; Lombardi, M; Meloni, A; Pepe, A; Positano, V; Quarta, A; Restaino, G | 1 |
Hartman, RP; Hesley, GK; Hunt, CH | 1 |
Bulman, J; Klemm, B; Pandharipande, PV; Pedrosa, I; Rofsky, NM; Sena, BF; Stern, JP | 1 |
Thomsen, HS | 1 |
Bolus, DN; Lockhart, ME; Morgan, DE; Spann, JS; Winningham, B | 1 |
Abujudeh, HH; Alkasab, TK; Kaewlai, R; Kay, J; Narin, O; Nazarian, RM; Wang, Y | 1 |
Bennett, CL; Bookstaver, PB; Cournoyer, D; Cowper, S; Kahn, A; Locatelli, F; Lopez, I; Luminari, S; Macdougall, IC; Mattison, DR; Miller, AD; Murday, A; Norris, LB; Qureshi, ZP; Ray, P; Sartor, O; Starko, KM; Thomsen, HS; Trenery, A; Xirasagar, S | 1 |
Danford, DA; Duncan, KF; Fletcher, SE; Hammel, JM; Harvey, L; Kutty, S; Li, L; Rangamani, S; Varghese, J | 1 |
Martincich, L; Rachetta, E; Spinelli, R | 1 |
Karczmar, GS; Medved, M; Newstead, GM | 1 |
Wetzels, JF | 1 |
Ponder, SW | 1 |
7 review(s) available for gadolinium and Adverse Drug Event
Article | Year |
---|---|
Ten Things You Might Not Know about Iron Oxide Nanoparticles.
Topics: Abdomen; Animals; Brain; Clinical Trials, Phase III as Topic; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Rats | 2017 |
Gadolinium-Based Contrast Agent-Related Toxicities.
Topics: Animals; Brain; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Magnetic Resonance Imaging; Models, Biological | 2018 |
Use and Safety of Gadolinium Based Contrast Agents in Pediatric MR Imaging.
Topics: Brain; Child; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Pediatrics; Tomography, X-Ray Computed | 2019 |
Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction.
Topics: Acute Kidney Injury; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Gadolinium; Humans; Incidence; Prevalence; Risk Factors | 2015 |
Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Kidney; Kidney Failure, Chronic | 2009 |
Recent hot topics in contrast media.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Iodine; Magnetic Resonance Imaging; Tomography, X-Ray Computed | 2011 |
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).
Topics: Aspirin; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Female; Gadolinium; Humans; Male; Nephrogenic Fibrosing Dermopathy; Prevalence; Prognosis; Red-Cell Aplasia, Pure; Reye Syndrome; Risk Assessment; South Carolina; Survival Rate | 2012 |
1 trial(s) available for gadolinium and Adverse Drug Event
Article | Year |
---|---|
Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies.
Topics: Adolescent; Adult; Child; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Hemoglobinopathies; Humans; Kidney Diseases; Male; Young Adult | 2009 |
17 other study(ies) available for gadolinium and Adverse Drug Event
Article | Year |
---|---|
Contrast Media Adverse Drug Reactions in Highly Polluted Environment.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Iodine; Pharmacovigilance | 2022 |
The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2022 |
Duchenne muscular dystrophy patients: troponin leak in asymptomatic and implications for drug toxicity studies.
Topics: Biomarkers; Cardiomyopathies; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Muscular Dystrophy, Duchenne; Troponin I | 2022 |
Gena Norris and gadolinium deposition disease-the impact of celebrity health disclosure on public awareness.
Topics: Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Internet; Magnetic Resonance Imaging; Mass Media; Public Opinion; Search Engine | 2018 |
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.
Topics: Contrast Media; Cooperative Behavior; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Male; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pharmacovigilance; Registries; United States | 2014 |
2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Contrast Media; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Europe; Gadolinium; Humans; Magnetic Resonance Imaging; Patient Safety; Registries; Risk Assessment; Risk Factors; Severity of Illness Index | 2015 |
Gadolinium in Humans: A Family of Disorders.
Topics: Brain Diseases; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Terminology as Topic | 2016 |
Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Comorbidity; Contrast Media; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Italy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms; Prevalence; Respiration Disorders; Retrospective Studies; Risk Factors | 2016 |
Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Incidence; Iodine; Male; Middle Aged; Minnesota; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Young Adult | 2009 |
Screening patients to assess renal function before administering gadolinium chelates: assessment of the Choyke questionnaire.
Topics: Adult; Aged; Aged, 80 and over; Boston; Chelating Agents; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Magnetic Resonance Imaging; Male; Mass Screening; Middle Aged; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires; Young Adult | 2010 |
Assessment of adverse reaction rates during gadoteridol-enhanced MR imaging in 28,078 patients.
Topics: Alabama; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Heterocyclic Compounds; Humans; Incidence; Magnetic Resonance Imaging; Male; Organometallic Compounds; Risk Assessment; Risk Factors | 2011 |
Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Guideline Adherence; Humans; Incidence; Magnetic Resonance Imaging; Male; Massachusetts; Middle Aged; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Young Adult | 2011 |
Safety of cardiac magnetic resonance and contrast angiography for neonates and small infants: a 10-year single-institution experience.
Topics: Anesthetics, General; Bradycardia; Comorbidity; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Hypothermia; Incidence; Infant; Infant, Newborn; Longitudinal Studies; Magnetic Resonance Angiography; Magnetic Resonance Imaging, Cine; Male; Nebraska; Retrospective Studies; Risk Assessment | 2012 |
Do we really need new contrast agents for MR-mammography?
Topics: Breast Neoplasms; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Mammography; Needs Assessment; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Do we really need contrast agents?
Topics: Breast Neoplasms; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Female; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Mammography; Needs Assessment; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Thorotrast toxicity: the safety of gadolinium compounds.
Topics: Carcinogens; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Hemangiosarcoma; Humans; Liver Neoplasms; Risk Factors; Thorium Dioxide | 2007 |
Clinical use of bone densitometry in children: are we ready yet?
Topics: Absorptiometry, Photon; Adolescent; Adult; Americium; Bone and Bones; Bone Density; Calcium, Dietary; Child; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Gadolinium; Humans; Iodine Radioisotopes; Male; Minerals; Radioisotopes | 1995 |